Cargando…
A Novel Genetic Screen Identifies Modifiers of Age-Dependent Amyloid β Toxicity in the Drosophila Brain
The accumulation of amyloid β peptide (Aβ) in the brain of Alzheimer’s disease (AD) patients begins many years before clinical onset. Such process has been proposed to be pathogenic through the toxicity of Aβ soluble oligomers leading to synaptic dysfunction, phospho-tau aggregation and neuronal los...
Autores principales: | Belfiori-Carrasco, Lautaro F., Marcora, María S., Bocai, Nadia I., Ceriani, M. Fernanda, Morelli, Laura, Castaño, Eduardo M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349081/ https://www.ncbi.nlm.nih.gov/pubmed/28352227 http://dx.doi.org/10.3389/fnagi.2017.00061 |
Ejemplares similares
-
Amyloid peptides ABri and ADan show differential neurotoxicity in transgenic Drosophila models of familial British and Danish dementia
por: Marcora, María S, et al.
Publicado: (2014) -
Using Drosophila to identify naturally occurring genetic modifiers of amyloid beta 42- and tau-induced toxicity
por: Yang, Ming, et al.
Publicado: (2023) -
Phenotypic analysis of a transgenic Drosophila model of Alzheimer’s amyloid-β toxicity
por: Sekiya, Michiko, et al.
Publicado: (2021) -
Large-Scale Screen for Modifiers of Ataxin-3-Derived Polyglutamine-Induced Toxicity in Drosophila
por: Voßfeldt, Hannes, et al.
Publicado: (2012) -
A Drosophila screen identifies NKCC1 as a modifier of NGLY1 deficiency
por: Talsness, Dana M, et al.
Publicado: (2020)